Demographic and clinical characteristics of study populations (N = 594).

1<p>Participants with mania were assessed at time of evaluation during the hospital stay.</p>2<p>Multi-episode schizophrenia, n = 233.</p>3<p>Multi-episode schizophrenia, n = 228; Non-psychiatric controls, n = 205.</p>4<p>RBANS = Repeatable Battery for the Assessment of Neuropsychological Status.</p>5<p>PANSS = Positive and Negative Syndrome Scale.</p>6<p>YMRS = Young Mania Rating Scale.</p>7<p>Ham-D = Hamilton Rating Scale for Depression.</p

Psychiatric medications received by study participants.

1<p>Medications were recorded for the mania group at time of evaluation during the hospital stay. For all other groups, the medications are those received at the time of the one study visit.</p

Odds of Low Cognitive Scores by Elevation of CMV Antibody Level.

<p>RBANS =  Repeatable Battery for the Assessment of Neuropsychological Status; Imm Memory  =  Immediate Memory; Viscon =  Visuospatial/Constructional; DelMemory  =  Delayed Memory. LetNum  =  Letter Number Sequencing Test. Wisc % Per Er =  Wisconsin Card Sorting Test, % perseverative errors. Trails A =  Trail Making Test, Part A. Adjusted for age, gender, race (Caucasian vs. other), maternal education, and education. *p<.05; **p<.01.</p

Association between CMV IgG Antibody Levels and Cognitive Scores (N = 521).

1<p>Adjusted for age, gender, race, maternal education, and participant education.</p>2<p>RBANS =  Repeatable Battery for the Assessment of Neuropsychological Status; total score and index scores.</p>3<p>Letter Number Sequencing, scale score.</p>4<p>WCST =  Wisconsin Card Sorting Test.</p>5<p>Trail Making Test, part A, scale score.</p